The global organ preservation market size is calculated at USD 290.86 billion in 2025 and is forecasted to reach around USD 513.96 billion by 2034, accelerating at a CAGR of 6.53% from 2025 to 2034. The North America market size surpassed USD 125.59 billion in 2024 and is expanding at a CAGR of 6.65% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Organ Preservation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Organ Preservation Market, by Solution
8.1.1 University of Wisconsin (UW)
8.1.1.1. Market Revenue and Forecast
8.1.2. Perfadex
8.1.2.1. Market Revenue and Forecast
8.1.3. Custodial HTK
8.1.3.1. Market Revenue and Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Forecast
9.1. Organ Preservation Market, by Organ Type
9.1.1. Kidneys
9.1.1.1. Market Revenue and Forecast
9.1.2. Heart
9.1.2.1. Market Revenue and Forecast
9.1.3. Lung
9.1.3.1. Market Revenue and Forecast
9.1.4. Liver
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. Organ Preservation Market, by Preservation Technique
10.1.1. Static Cold Storage
10.1.1.1. Market Revenue and Forecast
10.1.2. Normothermic Machine Perfusion
10.1.2.1. Market Revenue and Forecast
10.1.3. Hypothermic Machine Perfusion
10.1.3.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Solution
11.1.2. Market Revenue and Forecast, by Organ Type
11.1.3. Market Revenue and Forecast, by Preservation Technique
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Solution
11.1.4.2. Market Revenue and Forecast, by Organ Type
11.1.4.3. Market Revenue and Forecast, by Preservation Technique
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Solution
11.1.5.2. Market Revenue and Forecast, by Organ Type
11.1.5.3. Market Revenue and Forecast, by Preservation Technique
11.2. Europe
11.2.1. Market Revenue and Forecast, by Solution
11.2.2. Market Revenue and Forecast, by Organ Type
11.2.3. Market Revenue and Forecast, by Preservation Technique
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Solution
11.2.4.2. Market Revenue and Forecast, by Organ Type
11.2.4.3. Market Revenue and Forecast, by Preservation Technique
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Solution
11.2.5.2. Market Revenue and Forecast, by Organ Type
11.2.5.3. Market Revenue and Forecast, by Preservation Technique
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Solution
11.2.6.2. Market Revenue and Forecast, by Organ Type
11.2.6.3. Market Revenue and Forecast, by Preservation Technique
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Solution
11.2.7.2. Market Revenue and Forecast, by Organ Type
11.2.7.3. Market Revenue and Forecast, by Preservation Technique
11.3. APAC
11.3.1. Market Revenue and Forecast, by Solution
11.3.2. Market Revenue and Forecast, by Organ Type
11.3.3. Market Revenue and Forecast, by Preservation Technique
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Solution
11.3.4.2. Market Revenue and Forecast, by Organ Type
11.3.4.3. Market Revenue and Forecast, by Preservation Technique
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Solution
11.3.5.2. Market Revenue and Forecast, by Organ Type
11.3.5.3. Market Revenue and Forecast, by Preservation Technique
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Solution
11.3.6.2. Market Revenue and Forecast, by Organ Type
11.3.6.3. Market Revenue and Forecast, by Preservation Technique
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Solution
11.3.7.2. Market Revenue and Forecast, by Organ Type
11.3.7.3. Market Revenue and Forecast, by Preservation Technique
11.4. MEA
11.4.1. Market Revenue and Forecast, by Solution
11.4.2. Market Revenue and Forecast, by Organ Type
11.4.3. Market Revenue and Forecast, by Preservation Technique
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Solution
11.4.4.2. Market Revenue and Forecast, by Organ Type
11.4.4.3. Market Revenue and Forecast, by Preservation Technique
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Solution
11.4.5.2. Market Revenue and Forecast, by Organ Type
11.4.5.3. Market Revenue and Forecast, by Preservation Technique
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Solution
11.4.6.2. Market Revenue and Forecast, by Organ Type
11.4.6.3. Market Revenue and Forecast, by Preservation Technique
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Solution
11.4.7.2. Market Revenue and Forecast, by Organ Type
11.4.7.3. Market Revenue and Forecast, by Preservation Technique
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Solution
11.5.2. Market Revenue and Forecast, by Organ Type
11.5.3. Market Revenue and Forecast, by Preservation Technique
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Solution
11.5.4.2. Market Revenue and Forecast, by Organ Type
11.5.4.3. Market Revenue and Forecast, by Preservation Technique
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Solution
11.5.5.2. Market Revenue and Forecast, by Organ Type
11.5.5.3. Market Revenue and Forecast, by Preservation Technique
12.1. XVIVO
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. TransMedics, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. 21st Century Medicine
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bridge to Life Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Preservation Solutions, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Global Transplant Solutions
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Organ Recovery Systems
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. CryoLife, Inc. (Artivion, Inc)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Paragonix Technologies, Inc (Getinge)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample